This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Index funds carry risks for retirees, including sequence of returns and drawdown volatility. Learn strategies to mitigate these concerns.
22,186 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Long-term wealth isn’t built on quick trades. It comes from steady income and durable growth. Here are two monster di...
The U.S. Department of Housing and Urban Development has opened a Fair Housing Act investigation into Washington stat...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
When a loved one disappears or faces a personal crisis, money can feel like an extra weight. This guide offers practi...
Big investors are quietly using a loophole to keep buying rental properties despite bans. This article breaks down wh...
Bitcoin price falls below a crucial support level as traders weigh macro signals and rising leverage. The move raises...
Sprott just bought a large stake in its own stock. What does this mean for investors? This guide breaks down the impl...
As markets wobble in 2026, suze orman’s sober advice guides grieving spouses to pause large financial actions for six...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
A high-profile clash between the Pentagon and a leading AI firm hits markets and wallets. Regulators, investors, and ...